What is the average shipment value for India to North Korea pharmaceutical trade?

$15.7K per consignment across 1 shipments.

How many Indian pharmaceutical companies export to North Korea?

1 Indian companies. Largest: ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED with $15.7K.

How can I find verified Indian pharmaceutical suppliers for North Korea?

TransData Nexus covers 1 active exporters with shipment history and trade values at transdatanexus.com.

India to North Korea Pharmaceutical Export (2026) — $15.7K, 1 Suppliers | TransData Nexus

India to North Korea Pharmaceutical Export (2026) — $15.7K, 1 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to North Korea

#	Formulation	Value	Share
1	Cytarabine Injection. 2 G Kr - F000210842	$15.7K	100.0%

India exports 1+ pharmaceutical formulations to North Korea with a combined trade value of $15.7K. Key products include Cytarabine ($16K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 1 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to North Korea Trade Routes

1Cytarabine$16K

These are the top pharmaceutical products exported from India to North Korea, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, North Korea buyers, regulatory requirements, and logistics for that specific product corridor. Products include Cytarabine ($16K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to North Korea

1Zydus Hospira Oncology Private Limited

$16K

1 Indian pharmaceutical companies export finished formulations to North Korea. Leading exporters include Zydus Hospira Oncology Private Limited, . The top exporter accounts for 100.0% of total India–North Korea pharma exports. Source: Indian Customs (DGFT).

Top North Korea Buyers from India

1Xxizexxserxxce Xxmpaxx Bv

$16K

1 companies in North Korea import pharmaceutical formulations from India. Top buyers include . The largest buyer accounts for 100.0% of India–North Korea pharma imports. Source: Indian Customs (DGFT).

Port Analysis — India to North Korea Pharmaceutical Shipments

Indian Export Ports

ZYDUS INFRASTRUCTURE PRIVATE SEZ100.0%

North Korea Import Ports

Port data not available

Trade Statistics

Total Value$16K

Shipments1

Indian Exporters1

North Korea Buyers1

Avg Shipment$16K

Products1

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to North Korea?

India exported pharmaceuticals worth $15.7K to North Korea across 1 verified shipments.

Who are the top Indian pharmaceutical exporters to North Korea?

1. ZYDUS HOSPIRA ONCOLOGY PRIVATE LIMITED — $15.7K. Total: 1 suppliers.

Which companies in North Korea import pharmaceuticals from India?

1. XXIZEXXSERXXCE XXMPAXX BV — $15.7K. 1 buyers total.

What pharmaceutical products does India export most to North Korea?

1. Cytarabine Injection. 2 G Kr - F000210842 ($15.7K, 100.0%)

Which ports handle pharmaceutical shipments from India to North Korea?

Export: ZYDUS INFRASTRUCTURE PRIVATE SEZ. Import: .

Why does North Korea import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $15.7K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply North Korea?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to North Korea identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 1 verified shipments from 1 Indian exporters to 1 North Korea buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1 Exporters

1 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to North Korea Pharmaceutical Export